Macrolide antibiotics: the analysis of socio-economic affordability

Authors

  • N. O. Matyashova National University of Pharmacy, Ukraine
  • A. I. Yemets National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/cphj.16.1393

Keywords:

antibiotics, affordability, macrolides, coefficient of the solvency adequacy

Abstract

The structure of the pharmaceutical market of macrolide antibiotics in Ukraine has been analyzed; the coefficient of the solvency adequacy has been calculated within the period of 2012-2014. The analysis of the range of drugs and their socio-economic affordability was conducted during 2012-2014 according to the data of Morion Pharmstandard Analytical Market Research System. To conduct the analysis of socio-economic affordability of drugs the coefficient of the solvency adequacy (Ca.s) expressed in the proportion of the average wage spent on the purchase of one drug package has been calculated. According to the data for 2015 macrolide antibiotics are presented in sufficient quality at the Ukrainian pharmaceutical market: 132 TNs taking into account their dosage forms. The number of foreign drugs exceeds domestic supply: 82 and 50 TNs, respectively. The analysis of the pharmaceutical market for 2012-2015 has shown a downward tendency in the total number of offers for macrolides: from 172 TNs in 2012 to 132 TNs in 2015. However, as this study shows, this reduction is solely due to foreign drugs. The number of domestic offers is unchanged over time. Macrolide antibiotics are presented in a wide range, as well as in a various price range, and their high affordability allows patients to choose the drug taking into account its economic opportunities.

References

Программный комплекс «Аптека» компании «Морион» [Електронний ресурс] – Режим доступу: http: //pharmbase.com.ua/poisk/.

Critchley I.A., Brown S.D., Traczewski M.M. et al. // Antimicrob. Agents Chemother. – 2007. – Vol. 51 (12). – P. 4382-4389.

Jenkins S.G., Brown S.D., Farrell D.J. // Ann. Clin. Microbiol. Antimicrob. – 2008. – Vol. 7. – P. 1.

Jenkins S.G., Farrell D.J. // Emerg. Infect. Dis. – 2009. – Vol. 15 (8). – P. 1260-1264.

Sahm D.F., Brown N.P., Draghi D.C. et al. // Postgrad. Med. – 2008. – Vol. 120, №3 (Suppl 1). – P. 8-15.

Sahm D.F., Brown N.P., Thornsberry C. et al. // Postgrad. Med. – 2008. – Vol. 120, №3 (Suppl 1). – P. 16-24.

Downloads

Published

2016-06-14

Issue

Vol. 20 No. 2 (2016)

Section

Pharmacoeconomics

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).